A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Clinical trial NCT07349641 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07349641
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Start date: 2026-07-06
Primary completion: 2028-12-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.